نتایج جستجو برای: cd133 cells

تعداد نتایج: 1384053  

2015
TING SUN GUILIN CHEN YANYAN LI XUESHUN XIE YOUXIN ZHOU ZIWEI DU

Glioblastoma multiforme is the most common and fatal primary brain tumor in adults. Aggressive invasion of glioblastoma cells into brain tissue often limits complete surgical resection and contributes to therapeutic resistance. The cell surface marker, CD133, has been identified as a putative stem cell marker in normal and malignant brain tissues; CD133-/A2B5+ cells exhibit neural stem-like cel...

2011
Erika Bourseau-Guilmain Audrey Griveau Jean-Pierre Benoit Emmanuel Garcion

As the pentaspan stem cell marker CD133 was shown to bind cholesterol and to localize in plasma membrane protrusions, we investigated a possible function for CD133 in endocytosis. Using the CD133 siRNA knockdown strategy and non-differentiated human colon cancer Caco-2 cells that constitutively over-expressed CD133, we provide for the first time direct evidence for a role of CD133 in the intrac...

2013
Stuart C. Williamson Anastasia C. Hepburn Laura Wilson Kelly Coffey Claudia A. Ryan-Munden Deepali Pal Hing Y. Leung Craig N. Robson Rakesh Heer

Stem cells are thought to be the cell of origin in malignant transformation in many tissues, but their role in human prostate carcinogenesis continues to be debated. One of the conflicts with this model is that cancer stem cells have been described to lack androgen receptor (AR) expression, which is of established importance in prostate cancer initiation and progression. We re-examined the expr...

2017
Aiqun Liu Qingyun Yu Zhongxing Peng Yeqing Huang Shengpeng Diao Jing Cheng Wentao Wang Mingfan Hong

MicroRNA-200b (miR-200b) is a tumor suppressor in multiple tumor types, including gastric cancer, breast cancer, ovarian cancer and glioma. The biological significance of a known normal and cancer stem cell marker, CD133, remains elusive. The aim of the present study was to identify the function and mechinism of miR-200b in suppressing CD133+ glioma cells. CD133+ glioma cells were sorted by flo...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2009
Giulia Bertolini Luca Roz Paola Perego Monica Tortoreto Enrico Fontanella Laura Gatti Graziella Pratesi Alessandra Fabbri Francesca Andriani Stella Tinelli Elena Roz Roberto Caserini Salvatore Lo Vullo Tiziana Camerini Luigi Mariani Domenico Delia Elisa Calabrò Ugo Pastorino Gabriella Sozzi

The identification of lung tumor-initiating cells and associated markers may be useful for optimization of therapeutic approaches and for predictive and prognostic information in lung cancer patients. CD133, a surface glycoprotein linked to organ-specific stem cells, was described as a marker of cancer-initiating cells in different tumor types. Here, we report that a CD133+, epithelial-specific...

2015
June K. Wu Christopher Kitajewski Maia Reiley Connie H. Keung Julie Monteagudo John P. Andrews Peter Liou Arul Thirumoorthi Alvin Wong Jessica J. Kandel Carrie J. Shawber

Lymphatic malformations (LMs) are vascular anomalies thought to arise from dysregulated lymphangiogenesis. These lesions impose a significant burden of disease on affected individuals. LM pathobiology is poorly understood, hindering the development of effective treatments. In the present studies, immunostaining of LM tissues revealed that endothelial cells lining aberrant lymphatic vessels and ...

2015
Massimo Moro Giulia Bertolini Ugo Pastorino Luca Roz Gabriella Sozzi

The existence of specific cellular subpopulations within primary tumors with increased tumorigenic potential and chemotherapy resistance (tumor-initiating cells, TICs) holds great therapeutic implications. Resistant cells can remain quiescent for long periods and be responsible for local relapses and metastasis. We and others have previously described in non-small-cell lung cancer the presence ...

Journal: :Genetics and molecular research : GMR 2017
C Zhao Z G Ma S L Mou Y X Yang Y H Zhang W C Yao

MiR-200b, a member of the microRNA-200 family, has been identified to be capable of suppressing glioma cell growth through targeting CREB1 or CD133. However, whether miR-200b affects the biological behavior (proliferation, invasion, and migration) of glioma cells is poorly understood. The aim of this study was to evaluate the effect of miR-200b on the biological behavior of glioma cells in vitr...

Journal: :Journal of clinical pathology 2004
W Hilbe S Dirnhofer F Oberwasserlechner T Schmid E Gunsilius G Hilbe E Wöll C M Kähler

AIMS Recent results generated in a mouse model suggest that tumour angiogenesis/vasculogenesis can be initiated and maintained by bone marrow derived endothelial progenitor cells. This present study investigated the distribution and frequency of CD133 positive endothelial progenitor cells in patients with non-small cell lung cancer (NSCLC) (tumour tissue and tumour free lung regions) and health...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید